Tine, B. A. V., Allred, J. B., Hensley, M. L., Arend, R. C., Charlson, J. A., D'Amato, G. Z., LEE, T., Loggers, E. T., Berg, S. A., Ingham, M., Mandrekar, S. J., Munster, P. N., Schwartz, G. K. (2025). Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior chemotherapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.11507